Medical/Pharmaceuticals
StoneWise AI-driven Drug Discovery Platform: Investigation and Repurpose of Nucleoside-based RNA Polymerase Inhibitors and Their Potential Use in COVID-19 Infection Treatment
BEIJING, Feb. 20, 2020 /PRNewswire/ -- In a campaign to screen drugs for the treatment of COVID-19, the disease caused by SARS-CoV-2, StoneWise, a company specialized in applying artificial intelligence to innovative drug design solutions for innovative drug R&D enterprises and institutions, has ...
2020-02-20 20:04
1302
111 Partners with Financial Institutions in Battle Against Coronavirus
SHANGHAI, Feb. 20, 2020 /PRNewswire/ -- 111, Inc. (NASDAQ: YI, "111" or the "Company") has announced that it will leverage its knowhow and technology in the battle against the novel coronavirus (COVID-19) public health crisis, through partnerships with some ofChina's leading financial institution...
2020-02-20 17:00
5176
Ten billion investment to build Chengdu medical city to create a new highland for the international health industry
CHENGDU, China, Feb. 20, 2020 /PRNewswire/ -- In 2019, with the continuous advancement of "three medical integration", Chengdu Medical City's three medical innovation center, as "Western China Biomedical Innovation Center", submitted a satisfactory answer sheet: 58 new contracted projects (47 thr...
2020-02-20 16:04
661
VolitionRx Limited Schedules Full Year 2019 Earnings Conference Call and Business Update
AUSTIN, Texas, Feb. 18, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced it will host a conference call onFriday, February 21 at 8:30 a.m. Eastern time to discuss its financial and operating results for the fourth quarter and full year 2019, in conjunctio...
2020-02-19 05:10
10081
Transcenta Achieves Major Milestone in Continuous Perfusion Cell Culture Platform to Provide Industry Leading Productivity and Speed to Manufacturing
SUZHOU and HANGZHOU, China, Feb. 18, 2020 /PRNewswire/ -- Transcenta, a global biotherapeutics company that fully integrates antibody-based biotherapeutics discovery, R&D, regulatory affairs and manufacturing, today announced it has achieved a major milestone in its continuous perfusion cell cult...
2020-02-19 00:00
683
Henlius successfully held its fourth Scientific Advisory Board (SAB) meeting
SHANGHAI, Feb. 18, 2020 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK, Henlius), a global biologics company specialized in the discovery and development of high-quality and affordable antibodies for the treatment of patients with cancer and autoimmune diseases, recently held its fourth ...
2020-02-18 21:59
6364
Volition Unveils Its Epigenetic Toolbox
AUSTIN, Texas, Feb. 18, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that research on its Nu.Q(TM) Capture program has led to the development of a suite of novel epigenetic tools building on the breakthroughs announced last month on its assay platform...
2020-02-18 21:30
8456
Ally Bridge Group Leads US$70 million Investments in Two Israeli Life Science Companies over the Last 2 Months
TEL AVIV, Israel, HONG KONG and NEW YORK, Feb. 18, 2020 /PRNewswire/ — Ally Bridge Group ("ABG"), a leading global life science investment group, has announced that it recently ledUS$70 million investments in two Israeli life science companies over the last 2 months. Each of the two companies is ...
2020-02-18 21:30
1531
WAT Medical's study finds that HeadaTerm TENS Therapy Provides a Fast Treatment for Acute Migraines in a Randomized Controlled Trial
VANCOUVER, Feb. 14, 2020 /PRNewswire/ -- WAT Medical is thrilled to announce the newest clinical study conducted for an anti-migraine device by the HeadaTerm,for the treatment of migraines. The HeadaTerm TENS device was shown to decrease pain at an 11.8% better rate than many acute migraine medic...
2020-02-14 22:00
1384
Immuron reports diarrhea no.1 health issue for Americans on vacation
NEW YORK, Feb. 12, 2020 /PRNewswire/ -- Diarrhea remains the top health issue
facing Americans traveling to high risk countries, affecting 30 to 70 per
cent of travelers depending upon their destination, according to
biopharmaceutical company Immuron Limited[1], [2].
2020-02-13 04:35
1029
Lianluo Smart Limited Announces Pricing of Approximately $2.2 Million Offering
BEIJING, Feb. 12, 2020 /PRNewswire/ -- Lianluo Smart Limited ("Lianluo Smart" or the "Company") (NASDAQ: LLIT), aChina based professional smart service and products provider announced today it has entered into a securities purchase agreement with certain accredited investors to purchase approxima...
2020-02-13 01:57
9678
GC Pharma Reports Full Year 2019 Results
All consolidated entities revenues grew plus compared to prior year YONGIN, South Korea, Feb. 12, 2020 /PRNewswire/ -- GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited results for the year ended31 December 201...
2020-02-12 22:00
9815
WuXi AppTec China Sites Resume Operations after Extended Lunar New Year Holiday
SHANGHAI, Feb. 12, 2020 /PRNewswire/ -- With the end of the extended Lunar New Year holiday, WuXi AppTec sites inChina have resumed operations today, with the exception of our site inWuhan, which will reopen when local regulations permit. These steps are being taken in compliance with disease con...
2020-02-12 20:00
1290
WuXi Biologics Provides Back-to-work Operation Update Related to the Coronavirus Outbreak
SHANGHAI, Feb. 11, 2020 /PRNewswire/ -- WuXi Biologics is closely monitoring the coronavirus outbreak. Our management team is working vigilantly to execute our Business Continuity Plan to mitigate any potential risk. All three operating sites inChina, namely Wuxi, Shanghai and Suzhou, will resume...
2020-02-12 08:00
6630
111 Partners with Winhealth to Offer "Free Refill + End-to-End Delivery" Services to Patients with Chronic Diseases
SHANGHAI, Feb. 11, 2020 /PRNewswire/ -- As the novel coronavirus epidemic continues to evolve inChina, the country has introduced controls to prevent the spread of the epidemic and reduce the risk of contagion. Among the measures adopted is home quarantine, which has created challenges for patien...
2020-02-12 06:00
7039
With favorable policies, the medical device industry may usher in explosive growth; Medtec China offers a platform to seize the business opportunities
SHANGHAI, Feb. 11, 2020 /PRNewswire/ -- Reccently, the demand for medical devices such as protective clothing and masks soared, as did demand for devices including POCT testing reagents for theIVD industry, nucleic acid extraction devices, gene sequencing technology,medical imaging devices such a...
2020-02-11 22:00
1042
Luye Pharma Grants Cipla Medpro Exclusive Distribution and Marketing Rights for Seroquel® and Seroquel XR® in South Africa and Certain Neighbouring Countries
HONG KONG, Feb. 10, 2020 /PRNewswire/ -- Luye Pharma Group has announced that it has entered into an exclusive distribution and marketing service agreement with Cipla Medpro South Africa (Pty) Limited (Cipla Medpro), for Seroquel® and Seroquel XR® in South Africa, Namibia and Botswana. Cipla Medp...
2020-02-11 08:51
1145
Yuyu's First Generic Newmacor's 5-year Cumulative Sales Surpasses 40 Million Capsules
* Lined up all the sold Newmacor capsules end-to-end would reach 1,043km * Future target growth is to reach blockbuster levels and exceed 10 billion KRW SEOUL, South Korea, Feb. 10, 2020 /PRNewswire/ -- Yuyu Pharma (CEO Robert Wonsang Yu, KRX: 000220) is celebrating the 5th anniversary of the ...
2020-02-10 22:00
1352
GenScript ProBio Screens anti-2019 nCoV Antibodies in Just 24 Hours
NANJING, China, Feb. 6, 2020 /PRNewswire/ -- On February 4, 4:46 a.m., escorted by public security officers, 8 transgenic mice for fully human antibodies immunized with antigen from 2019 nCoV from Rongchang District,Chongqing were brought by Chongqing Academy of Animal Sciences and Chongqing CAMA...
2020-02-06 22:46
1257
Global Cord Blood Corporation Appoints Mr. Siu Chuen Cheng as Independent Non-executive Director
HONG KONG, Feb. 6, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced the appointment of Mr.Siu Chuen Chen...
2020-02-06 19:30
6919
Week's Top Stories
Most Reposted
Troy Animal Healthcare Strengthens Quality Operations with Veeva Vault Quality
[Picked up by 325 media titles]
2024-05-17 07:00Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
[Picked up by 319 media titles]
2024-05-15 12:00
Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
[Picked up by 306 media titles]
2024-05-16 15:00
US-BASED PANDUIT ELEVATES MANUFACTURING LANDSCAPE WITH NEW STATE-OF-THE-ART PLANT IN JOHOR BAHRU, MALAYSIA
[Picked up by 276 media titles]
2024-05-16 09:39
Trip.com Group and Rezdy Join Forces to Offer New Travel Experiences Around the World
[Picked up by 229 media titles]
2024-05-14 18:07Most Read
Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
2024-05-15 12:00
10592
Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
2024-05-16 15:00
8993
US-BASED PANDUIT ELEVATES MANUFACTURING LANDSCAPE WITH NEW STATE-OF-THE-ART PLANT IN JOHOR BAHRU, MALAYSIA
2024-05-16 09:39
8504
Casio to Release G-SHOCK-Surfrider Foundation Collaboration
2024-05-15 09:00
7929
Traveloka strengthens sustainability pledge as world's first Platinum Sponsor of GSTC
2024-05-13 16:42
7333
